Cannabis stocks retreat as investors weigh the narrow scope of US rescheduling plans. The sector had seen an initial rally before prices pulled back in recent trading.
Cannabis company shares declined following an initial rally, as investors reacted to the limited scope of the United States government's rescheduling of the drug.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near United States
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Three tech giants near $1T: WSJ
Three of the world's most valuable startups are nearing trillion-dollar status.
23 blue states sue Trump administration over student loan crackdown on healthcare degrees
Twenty-three U.S. states sue the Trump administration over its move to restrict student loan forgiveness for healthcare degree holders, challenging the policy in court.
Trump to announce decision today with EPA's Regan
Donald Trump to announce decision today with EPA Administrator Michael Regan.
Turkey sells almost all US Treasury holdings in March, data shows
Turkey liquidated nearly all of its US Treasury holdings in March, according to financial data.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.